Trial intelligence / Profile preview

Testosterone Replacement for Bone Density in Male Anorexia Nervosa

NCT00853502Phase 2Withdrawn

Sponsor
Massachusetts General Hospital
Start
Dec 2008
Primary completion
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of testosterone cypionate in Hypogonadism, low bone mineral density, sponsored by Massachusetts General Hospital. Planned start Dec 2008; status: withdrawn.

02

Drugs

testosterone cypionate
03

Conditions

Hypogonadismlow bone mineral density

Beyond the preview

Go deeper on NCT00853502.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00853502.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call